Cosentyx Drug Market Outlook: Biologic Therapy Growth in Autoimmune Diseases
The Cosentyx Drug Market is witnessing sustained growth as clinicians increasingly adopt targeted biologic therapies for the treatment of multiple autoimmune and inflammatory conditions. Cosentyx (secukinumab) is a monoclonal antibody that inhibits interleukin-17A, widely used in moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and related indications. Growth in the Cosentyx market reflects expanding … Read more